As of 2026-09-10, the Fair Value of Algernon Pharmaceuticals Inc (AGN.CN) is -1.48 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.60 CAD, the upside of Algernon Pharmaceuticals Inc is -347.06%.
With the market price of 0.60 CAD and our fair value calculation, Algernon Pharmaceuticals Inc (AGN.CN) is not a good investment. Investing in AGN.CN stocks now will result in a potential loss of 347.06%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-08-31 | 2022-08-31 | 2023-08-31 | 2024-08-31 | 2025-08-31 | 5Y Avg | |
| Net income | -7.73 | -6.05 | -6.78 | -0.50 | -1.72 | -4.56 |
| YoY growth | 9.42% | 21.72% | -12.01% | 92.58% | -241.38% | -25.93% |
| Market Cap (mil) | 3.91 |
| P/E | |
| Forward P/E |
| EPS | -0.30 |
| Avg earnings growth rate | -25.93% |
| TTM earnings | -1.93 |